Transition From Ambrisentan To Bosentan In Pulmonary Arterial Hypertension: A Single Center Prospective Study

被引：0
|
作者：
Gong, S. -G. [1 ]
Wang, L. [1 ]
Bigyan, P. [1 ]
Yuan, P. [1 ]
Zhao, Q. -H. [1 ]
Rong, J. [1 ]
He, J. [1 ]
Wu, W. -H. [1 ]
Zhang, R. [1 ]
Liu, J. -M. [1 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2275
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study
    Gong, Su-Gang
    Wang, Lan
    Pudasaini, Bigyan
    Yuan, Ping
    Jiang, Rong
    Zhao, Qin-Hua
    He, Jing
    Zhang, Rui
    Wu, Wen-hui
    Liu, Jin-Ming
    Zhou, Cai-cun
    CANADIAN RESPIRATORY JOURNAL, 2018, 2018
  • [2] Transition from Bosentan to Ambrisentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study
    Chen, Jingyuan
    Luo, Jun
    Yang, Xiaojie
    Luo, Peng
    Chen, Yusi
    Li, Zilu
    Li, Jiang
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2101 - 2107
  • [3] Edema in Patient Switched to Macitentan from Bosentan and Ambrisentan in Pulmonary Arterial Hypertension
    Safdar, Zeenat
    Thakur, Aishwarya
    Frost, Adaani
    CHEST, 2015, 148 (04)
  • [4] The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study
    Chen, Yusi
    Luo, Jun
    Chen, Jingyuan
    Kotlyar, Eugene
    Li, Zilu
    Chen, Wenjie
    Li, Jiang
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [5] Impact of transition from Sitaxsentan to Ambrisentan in Pulmonary Arterial Hypertension
    Safdar, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [6] Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    Lindarte, Erika Fernanda
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (08) : 967 - 973
  • [7] Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
    Safdar, Zeenat
    VASCULAR HEALTH AND RISK MANAGEMENT, 2011, 7 : 119 - 124
  • [8] Pulmonary arterial hypertension: Patient transition from epoprostenol to bosentan
    Bshouty, Z
    Da Ponte, FM
    CHEST, 2003, 124 (04) : 89S - 89S
  • [9] The Safely Change From Bosentan To Ambrisentan In Pulmonary Hypertension (scoba-Ph) Study
    Bourge, R. C.
    Pamboukian, S. V.
    Tallaj, J. A.
    Smallfield, M. C.
    Acharya, D.
    Iturrizaga, J. C.
    Njoku, A. U.
    Le, D. D.
    Horton, G. L.
    Falola, M. I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [10] Ambrisentan for pulmonary arterial hypertension
    Rubin, Lewis J.
    Dufton, Christopher
    Gerber, Michael J.
    FUTURE CARDIOLOGY, 2005, 1 (04) : 425 - 432
12345